Association of neurotransmitter pathway polygenic risk with specific symptom profiles in psychosis
Tracy L. Warren, Justin D. Tubbs, Tyler A. Lesh, Mylena B. Corona, Sarvenaz Pakzad, Marina Albuquerque, Praveena Singh, Vanessa C. Zarubin, Sarah J. Morse, Pak Chung Sham, Cameron S. Carter, Alex S. Nord
This study links neurotransmitter pathway polygenic risk to specific symptom profiles in psychosis, identifying associations between glutamate and dopamine pathways with cognitive control and global functioning.
Molecular Psychiatry · Mar 15, 2024Peer-reviewedGenetic & Genomic Medicine